The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[2-Methyl-4-(3-phenoxyphenyl)-3-oxopentanoyl]pyrrolidine ID: ALA2269844
PubChem CID: 11792256
Max Phase: Preclinical
Molecular Formula: C22H25NO3
Molecular Weight: 351.45
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C(=O)C(C)c1cccc(Oc2ccccc2)c1)C(=O)N1CCCC1
Standard InChI: InChI=1S/C22H25NO3/c1-16(21(24)17(2)22(25)23-13-6-7-14-23)18-9-8-12-20(15-18)26-19-10-4-3-5-11-19/h3-5,8-12,15-17H,6-7,13-14H2,1-2H3
Standard InChI Key: UUPABTWOCOGHSN-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
13.6207 -4.1648 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7161 -4.9798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5235 -5.1332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9192 -4.4141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3564 -3.8186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9016 -3.7691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8854 -2.9504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1663 -2.5506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4633 -2.9737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4775 -3.7961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1966 -4.1917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.1521 -1.7282 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.7441 -2.5739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0392 -3.0006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3200 -2.6008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3059 -1.7784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0088 -1.3594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7280 -1.7551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6171 -3.0239 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9021 -2.6241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1971 -3.0508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4780 -2.6510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4638 -1.8286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1667 -1.4096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8859 -1.8053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5904 -2.5236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
1 5 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
6 11 2 0
8 12 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
13 18 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
20 25 2 0
19 20 1 0
15 19 1 0
9 13 1 0
7 26 1 0
1 6 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 351.45Molecular Weight (Monoisotopic): 351.1834AlogP: 4.41#Rotatable Bonds: 6Polar Surface Area: 46.61Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.01CX Basic pKa: ┄CX LogP: 4.47CX LogD: 4.47Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.72Np Likeness Score: -0.59
References 1. Cantín A, Moya P, Miranda MA, Primo J, Primo-Yúfera E.. (2000) Synthesis and biological evaluation of new analogues of the active fungal metabolites N-(2-methyl-3-oxodecanoyl)-2-pyrroline and N-(2-methyl-3-oxodec-8-enoyl)-2-pyrroline (II)., 48 (8): [PMID:10956170 ] [10.1021/jf990948g ]